ACM
ABBV icon

Ashford Capital Management’s AbbVie ABBV Stock Holding History

Ashford Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,390
Closed -$1.06M – 102
2024
Q3 		$1.06M Buy
5,390
+1,410
+35% +$263K 0.13% 75
2024
Q2 		$683K Buy
+3,980
New +$659K 0.09% 78
2023
Q2 		– Sell
-1,300
Closed -$207K – 90
2023
Q1 		$207K Hold
1,300
– – 0.03% 89
2022
Q4 		$210K Buy
+1,300
New +$199K 0.03% 88
2022
Q2 		– Sell
-1,300
Closed -$211K – 92
2022
Q1 		$211K Buy
+1,300
New +$189K 0.02% 100

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Ashford Capital Management's ABBV Position: Q4 2024 in Review

Ashford Capital Management sold out of AbbVie (ABBV) in Q4 2024, closing a stake of 5,390 shares — an estimated $1.06M sold.

Ashford Capital Management first reported a position in ABBV in Q1 2022 and held it in 5 quarters. The position peaked at $1.06M in Q3 2024. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Ashford Capital Management reported no remaining AbbVie position as of Q4 2024 after selling out during the quarter.
  • Ashford Capital Management sold 5,390 AbbVie shares in Q4 2024, an estimated $1.06M.
  • Ashford Capital Management first reported a position in AbbVie in Q1 2022 and held it in 5 quarters.
  • Ashford Capital Management's AbbVie position peaked at $1.06M in Q3 2024.
  • 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Ashford Capital Management's 13F filing for Q4 2024, filed 18 Feb 2025.